BuyersWhere are the buyers? The stock is trading below 2018 yet we have achieved many positive milestones, reduced the risk.
We are now below $100 million market cap yet many similar staged companies have much higher market caps in the $Billions.
They all have institutional ownership where we have zero%, in my opinion that falls directly back on management. What are they doing and why can't they generate interest from institutional big boys?
We are long overdue for the 3rd party independent phase 2 peer review, no
idea when we will receive or if it will even have any positive impact on share price. I am sure the one analyst who covers ARCH is scratching his head.
The new phase 2 AKI trial should be starting soon, I hope we get an update from management.
I am disappointed with share price and lack of buying interest. It is obvious that CIBC and Scotia are shorting the stock for about 12 months now but the real issue is the lack of buying, low volume. If there was serious buying interest the share price would be much higher.
I believe management have backed themselves into a corner here with regards to attracting institutional buyers do to the fact our share price is below $10, we are on the TSX Venture exchange, our market cap is below $1B and the volume and liquidity are a big concern for the big boys.
I am confident we will see stellar data and results from the new phase 2 AKI trial but the shorting action and trading suggests the markets are signaling dilution/capital raise in the future for a future phase 3 trial.